0001209191-21-008510.txt : 20210208 0001209191-21-008510.hdr.sgml : 20210208 20210208165430 ACCESSION NUMBER: 0001209191-21-008510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simon Barry J. CENTRAL INDEX KEY: 0001647994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37507 FILM NUMBER: 21602172 MAIL ADDRESS: STREET 1: 2533 SOUTH COAST HIGHWAY 101 STREET 2: SUITE 210 CITY: CARDIFF-BY-THE-SEA STATE: CA ZIP: 92007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantKwest, Inc. CENTRAL INDEX KEY: 0001326110 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431979754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 633-0300 MAIL ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Conkwest, Inc. DATE OF NAME CHANGE: 20140416 FORMER COMPANY: FORMER CONFORMED NAME: ZelleRx Corp DATE OF NAME CHANGE: 20050504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-05 0 0001326110 NantKwest, Inc. NK 0001647994 Simon Barry J. C/O NANTKWEST, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 1 1 0 0 See remarks Common Stock 2021-02-05 4 M 0 22100 1.9984 A 3192640 D Common Stock 2021-02-05 4 S 0 22100 23.089 D 3170540 D Stock Option (right to buy) 1.9984 2021-02-05 4 M 0 22100 0.00 D 2025-02-16 Common Stock 22100 110020 D The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019. Represents the weighted average share price of an aggregate total of 22,100 shares sold in the price range of $23.00 to $23.315 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015. President and Chief Administrative Officer /s/ Sonja Nelson, as Attorney-in-Fact 2021-02-08